Jane Street
ELDN icon

Jane Street’s Eledon Pharmaceuticals ELDN Stock Holding History

Jane Street’s Portfolio ELDN Stock Details ELDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-489,376
Closed -$1.15M – 11915
2025
Q4 		$739K Buy
489,376
+294,175
+151% +$699K ﹤0.01% 6825
2025
Q3 		$506K Buy
+195,201
New +$571K ﹤0.01% 7836
2025
Q2 		– Sell
-224,600
Closed -$761K – 9916
2025
Q1 		$761K Buy
224,600
+102,325
+84% +$421K ﹤0.01% 6071
2024
Q4 		$504K Buy
+122,275
New +$482K ﹤0.01% 6769
2023
Q3 		– Sell
-15,783
Closed -$21.6K – 8803
2023
Q2 		$21.6K Buy
+15,783
New +$32.9K ﹤0.01% 8353
2020
Q3 		– Sell
-2,341
Closed -$19K – 7293
2020
Q2 		$19K Buy
+2,341
New +$26.4K ﹤0.01% 6970
2019
Q3 		– Sell
-690
Closed -$13K – 5218
2019
Q2 		$13K Buy
+690
New +$30.2K ﹤0.01% 5031

Other funds holding ELDN

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
Defilade Capital Management Emeryville, California $712M AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return
ZP
Zimmer Partners New York $4.15B AUM 14.2% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
CCM
Catalio Capital Management New York $479M AUM 140.7% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return

Jane Street's ELDN Position: Q1 2026 in Review

Jane Street sold out of Eledon Pharmaceuticals (ELDN) in Q1 2026, closing a stake of 489,376 shares — an estimated $1.15M sold.

Jane Street first reported a position in ELDN in Q2 2019 and held it in 7 quarters. The position peaked at $761K in Q1 2025. 121 funds tracked by Wall St. Rank hold ELDN as of Q1 2026.

  • Jane Street reported no remaining Eledon Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Jane Street sold 489,376 Eledon Pharmaceuticals shares in Q1 2026, an estimated $1.15M.
  • Jane Street first reported a position in Eledon Pharmaceuticals in Q2 2019 and held it in 7 quarters.
  • Jane Street's Eledon Pharmaceuticals position peaked at $761K in Q1 2025.
  • 121 funds tracked by Wall St. Rank held Eledon Pharmaceuticals as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.